Cargando…
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias
BACKGROUND: Hereditary cerebellar ataxias are a group of disorders characterized by heterogeneous clinical mani-festations, progressive clinical course, and diverse genetic causes. No disease modifying treatments are yet available for many of these disorders. Oxidative stress has been recurrently id...
Autores principales: | Barca, Emanuele, Emmanuele, Valentina, DiMauro, Salvatore, Toscano, Antonio, Quinzii, Catarina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341493/ https://www.ncbi.nlm.nih.gov/pubmed/29119930 http://dx.doi.org/10.2174/1570159X15666171109125643 |
Ejemplares similares
-
Human Coenzyme Q(10) Deficiency
por: Quinzii, Catarina M., et al.
Publicado: (2006) -
Whole-Exome Sequencing Study of Fibroblasts Derived From Patients With Cerebellar Ataxia Referred to Investigate CoQ10 Deficiency
por: Monfrini, Edoardo, et al.
Publicado: (2023) -
Cerebellar BDNF Promotes Exploration and Seeking for Novelty
por: Laricchiuta, Daniela, et al.
Publicado: (2018) -
Upbeat Nystagmus in Late Onset Cerebellar Ataxia: Think of Anti-Glutamate Decarboxylase 65 Antibody-Associated Cerebellar Ataxia
por: Mahale, Rohan R., et al.
Publicado: (2021) -
Treatable cerebellar ataxias()
por: K.P., Divya, et al.
Publicado: (2020)